Toggle Side Panel
Close search

Multiple Sclerosis News Community › Forums › Trials and Research › MS Specialist to Lead Trial of Temelimab in Progressing Disease Without Relapses

  • Trials and Research

    MS Specialist to Lead Trial of Temelimab in Progressing Disease Without Relapses

    Posted by Community Member on December 9, 2019 at 7:22 am

    A clinical trial in Sweden will test temelimab, an antibody GeNeuro designed to help remyelination, in MS patients with disease progression and no relapses. Learn more about the trial here.

    Are you interested in following this research as it progresses?

    Community Member replied 6 years, 5 months ago 1 Member · 0 Replies
  • 0 Replies

Sorry, there were no replies found.

Log in to reply.

Start of Discussion
0 of 0 replies June 2018
Now

Report

Harassment or bullying behavior
Contains mature or sensitive content
Contains misleading or false information
Contains abusive or derogatory content
Contains spam, fake content or potential malware

Block Member?

Please confirm you want to block this member.

You will no longer be able to:

  • See blocked member's posts
  • Mention this member in posts
  • Invite this member to groups
  • Message this member
  • Add this member as a connection

Please note: This action will also remove this member from your connections and send a report to the site admin. Please allow a few minutes for this process to complete.

Report

You have already reported this .